iCAN Signs MoU With Yom Chai for Crohn’s Disease And Autism

the wide world of weed

ISRAEL: The Directors of Ananda Developments have announced that investee company iCAN has signed an MoU with a new Israeli Medical Cannabis company Yom Chai to develop and clinically validate cannabis based treatments for Crohn’s Disease, Autism and other neurodevelopmental, neurodegenerative and gastrointestinal diseases. Yom Chai has deep experience in the international medical cannabis market Read the full article…